India’s COVAXIN shows 81 per cent efficacy

ANS: India’s first indigenous developed coronavirus vaccine, COVAXIN, has demonstrated an interim vaccine efficacy of 81 percent in Phase 3 clinical trials, said Bharat Biotech, …